Riskpilot← Back to searchSign inGet full accessHAMAR HELSE - ANNESTESI AS
ASActiveOrg 987332751Karlsvognen 11, 2315 HamarOther human health activities n.e.c. · NACE 8699Est. 20040 employees
Revenue 2024
NOK 622K
+106% vs 2023
EBITDA margin
58.9%
+627% vs 2023
Equity ratio
11.4%
Financial strength
Net profit 2024
NOK -364K
-527% vs 2023
| Revenue | NOK 622K | +106% |
| EBITDA | NOK 366K | +627% |
| Net profit | NOK -364K | -527% |
| Total assets | NOK 4,4M | -10% |
| Equity | NOK 500K | -42% |
| Employees | 0 | — |
Legal name
HAMAR HELSE - ANNESTESI AS
Org number
987332751
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
23. oktober 2004
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Formidling av helsetjenester innen smertebehandling, annestesiservice, bedriftshelsetjeneste, fysikalsk medisin og sportsmedisin. Formidling av helsetjenester innen smertebehandling, annestesiservice, bedriftshelsetjeneste, fysikalsk medisin og sportsmedisin.
Address
Karlsvognen 11, 2315 Hamar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 369 | 330 | 160 | 302 | 622 |
| Staff expenses | −2 | −0 | −4 | −5 | −4 |
| EBITDA | 198 | 108 | −24 | 50 | 366 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 198 | 108 | −24 | 50 | 366 |
| Net financials | 92 | 256 | −256 | −109 | −693 |
| Profit before tax | 291 | 364 | −280 | −58 | −327 |
| Tax | 43 | 26 | −0 | −0 | 37 |
| Net profit | 248 | 338 | −280 | −58 | −364 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 593 | 3 925 | 3 578 | 4 876 | 4 380 |
| Equity | 865 | 1 203 | 923 | 865 | 500 |
| Long-term debt | 0 | 0 | 0 | 0 | 3 415 |
| Short-term debt | 2 728 | 2 722 | 2 655 | 4 011 | 465 |
| Total debt | 2 728 | 2 722 | 2 655 | 4 011 | 3 879 |
EBITDA margin
58.9%
This company
15.8%
Market median
+273% vs market
20202024
Equity ratio
11.4%
This company
38.2%
Market median
-70% vs market
20202024
Return on equity
-72.8%
This company
18.4%
Market median
-496% vs market
20202024
Net profit margin
-58.6%
This company
8.1%
Market median
-823% vs market
20202024
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
7.75×
This company
0.62×
Market median
-1150% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PH Chief Executive Officer | Chief Executive Officer | 2004 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2004 | |
| Board of Directors | 2004 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HAMAR HELSE - ANNESTESI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Hillestad Christensen | Chief Executive Officer | 0 companies |
| Tea Karoline Hillestad Walberg-Olstad | Board of Directors | 0 companies |
| Matias Hillestad Christensen | Board of Directors | 0 companies |